2024-25 Annual report
Financial highlights
Read the 2024-25 audited financial statements
Statement of operations and changes in net assets
Year ended March 31, 2025
Expenses | 2025 | 2024 |
---|---|---|
Decrease risk of people getting cancer in Canada | 3,681,283 | 2,381,154 |
Diagnose cancer faster, accurately and at an earlier stage | 9,214,088 | 4,943,768 |
Deliver high-quality care in a sustainable, world-class system | 2,177,000 | 1,415,758 |
Deliver supports for patients, families and caregivers | 5,364,356 | 1,902,124 |
Culturally appropriate care closer to home | 5,464,542 | 2,801,646 |
First Nations-, Inuit-, or Métis-governed research and data systems | 2,231,591 | 783,745 |
Transforming research into improved care | 8,499,632 | 7,727,850 |
Maximizing the impact of health system data to drive change and improving information flow among providers and patients | 7,398,720 | 4,526,999 |
Public engagement and outreach and cancer strategy program support | 7,037,354 | 6,000,931 |
51,068,566 | 32,483,975 | |
Operating expenses (Note 4)* | 10,680,861 | 11,040,412 |
61,749,427 | 43,524,387 |
Revenue | 2025 | 2024 |
---|---|---|
Government of Canada (Note 6)* | 61,637,178 | 42,537,277 |
Other funding | 112,249 | 987,110 |
61,749,427 |
|
Excess of revenue over expenses for the year, and net assets at the end of the year | – | – |
---|
Statement of financial position
As at March 31, 2025
Assets
Current | 2025 | 2024 |
---|---|---|
Cash | 3,046,075 | 7,184,587 |
Short-term investments | 2,997,188 | 10,584,961 |
Accounts receivable | 574,285 | 485,822 |
Projects in process – advances (Note 3)* | 1,040,126 | 995,186 |
Prepaid expenses | 2,060,523 | 1,414,791 |
9,718,197 |
| |
Capital assets (Note 4)* | 1,535,224 | 1,943,325 |
|
| |
11,253,421 |
|
Liabilities and net assets
Current | 2025 | 2024 |
---|---|---|
Accounts payable and accrued liabilities | 5,625,993 | 3,661,621 |
Government remittances payable (Note 6)* | 52,077 | 44,463 |
Deferred contributions – Expenses of future periods (Note 6 (a))* | 3,764,102 | 16,644,680 |
9,442,172 |
| |
Deferred contributions – Capital assets (Note 6 (b))* | 1,275,720 | 1,601,873 |
Lease inducements (Note 7)* | 535,529 | 656,035 |
1,811,249 |
| |
11,253,421 |
| |
Net assets | – | – |
11,253,421 |
|
*Refer to the audited financial statements for full details on the note.
Statement of cash flows
Year ended March 31, 2025
Increase (decrease) in cash
Operating activities | 2025 | 2024 |
---|---|---|
Government of Canada contributions received (Note 6)* | 47,500,000 | 47,500,000 |
Other contributions received | 236,868 | 898,549 |
Interest received on short-term investments | 930,447 | 806,061 |
Interest paid to Government of Canada | – | (64,151) |
Cash paid for programs and operating expenses | (60,613,830) | (46,624,371) |
11,946,515 |
|
Investing activities | 2025 | 2024 |
---|---|---|
Purchase of short-term investment | – | (6,000,000) |
Redemption of short-term investment | 8,000,000 | 4,000,000 |
8,000,000 | (2,000,000) |
Financing activities | 2025 | 2024 |
---|---|---|
Purchase of capital assets | (191,997) | (680,499) |
(191,997) |
|
Increase (decrease) in cash | (4,138,512) | (164,411) |
---|---|---|
Cash, beginning of year | 7,184,587 | 7,348,998 |
Cash, end of year | 3,046,075 | 7,184,587 |